Education
About Us
Working with TipRanks
Follow Us
Biogen (BIIB)
NASDAQ:BIIB
Total Valuation
Biogen has a market cap or net worth of $20.05B. The enterprise value is $22.26B.
Market Cap$20.05B
Enterprise Value$22.26B
Share Statistics
Biogen has 146,614,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding146,614,600
Owned by Insiders0.17%
Owned by Institutions20.25%
Financial Efficiency
Biogen’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.83%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.83%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee1.27M
Profits Per Employee214.62K
Employee Count7,605
Asset Turnover0.34
Inventory Turnover0.94
Valuation Ratios
The current PE Ratio of Biogen is 13.1. Biogen’s PEG ratio is ―.
PE Ratio13.1
PS Ratio―
PB Ratio―
Price to Fair Value1.33
Price to FCF―
Price to Operating Cash Flow9.40
PEG Ratio―
Income Statement
In the last 12 months, Biogen had revenue of 9.68B and earned 1.63B in profits. Earnings per share was 11.20.
Revenue9.68B
Gross Profit7.37B
Operating Income2.22B
Pretax Income1.91B
Net Income1.63B
EBITDA2.83B
Earnings Per Share (EPS)11.20
Cash Flow
In the last 12 months, operating cash flow was 2.12B and capital expenditures -260.00M, giving a free cash flow of 1.86B billion.
Operating Cash Flow2.12B
Free Cash Flow1.86B
Free Cash Flow per Share12.66
Dividends & Yields
Biogen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.63
52-Week Price Change-33.22%
50-Day Moving Average131.05
200-Day Moving Average137.71
Relative Strength Index (RSI)55.36
Average Volume (3m)1.45M
Important Dates
Biogen upcoming earnings date is Oct 22, 2025, Before Open (Confirmed).
Last Earnings DateJul 31, 2025
Next Earnings DateOct 22, 2025
Ex-Dividend Date―
Financial Position
Biogen as a current ratio of 1.35, with Debt / Equity ratio of 37.40%
Current Ratio1.35
Quick Ratio0.90
Debt to Market Cap0.28
Net Debt to EBITDA1.50
Interest Coverage Ratio8.86
Taxes
In the past 12 months, Biogen has paid 273.80M in taxes.
Income Tax273.80M
Effective Tax Rate0.14
Enterprise Valuation
Biogen EV to EBITDA ratio is 9.38, with an EV/FCF ratio of 10.55.
EV to Sales2.74
EV to EBITDA9.38
EV to Free Cash Flow10.55
EV to Operating Cash Flow9.23
Balance Sheet
Biogen has $2.76B in cash and marketable securities with $6.59B in debt, giving a net cash position of $3.84B billion.
Cash & Marketable Securities$2.76B
Total Debt$6.59B
Net Cash$3.84B
Net Cash Per Share$26.16
Tangible Book Value Per Share$3.75
Margins
Gross margin is 75.43%, with operating margin of 22.93%, and net profit margin of 16.87%.
Gross Margin75.43%
Operating Margin22.93%
Pretax Margin19.70%
Net Profit Margin16.87%
EBITDA Margin29.24%
EBIT Margin22.29%
Analyst Forecast
The average price target for Biogen is $170.70, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$170.70
Price Target Upside25.18% Upside
Analyst ConsensusModerate Buy
Analyst Count25
Revenue Growth Forecast3.48%
EPS Growth Forecast31.44%